Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA DIVIS LABORATORIES NATCO PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 13.3 66.0 20.2% View Chart
P/BV x 3.5 7.1 48.9% View Chart
Dividend Yield % 0.6 0.9 66.2%  

Financials

 NATCO PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
DIVIS LABORATORIES
Mar-23
NATCO PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs8474,641 18.2%   
Low Rs5022,730 18.4%   
Sales per share (Unadj.) Rs148.4292.6 50.7%  
Earnings per share (Unadj.) Rs39.268.7 57.1%  
Cash flow per share (Unadj.) Rs48.281.6 59.0%  
Dividends per share (Unadj.) Rs5.5030.00 18.3%  
Avg Dividend yield %0.80.8 100.2%  
Book value per share (Unadj.) Rs267.1480.9 55.5%  
Shares outstanding (eoy) m182.47265.47 68.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.512.6 36.1%   
Avg P/E ratio x17.253.7 32.1%  
P/CF ratio (eoy) x14.045.2 31.0%  
Price / Book Value ratio x2.57.7 32.9%  
Dividend payout %14.043.7 32.1%   
Avg Mkt Cap Rs m123,049978,378 12.6%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8679,750 49.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07177,675 34.9%  
Other income Rs m1,2853,447 37.3%   
Total revenues Rs m28,35681,122 35.0%   
Gross profit Rs m9,11723,691 38.5%  
Depreciation Rs m1,6383,432 47.7%   
Interest Rs m14520 739.8%   
Profit before tax Rs m8,61923,686 36.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4665,453 26.9%   
Profit after tax Rs m7,15318,234 39.2%  
Gross profit margin %33.730.5 110.4%  
Effective tax rate %17.023.0 73.9%   
Net profit margin %26.423.5 112.6%  
BALANCE SHEET DATA
Current assets Rs m30,00397,437 30.8%   
Current liabilities Rs m6,83115,331 44.6%   
Net working cap to sales %85.6105.7 81.0%  
Current ratio x4.46.4 69.1%  
Inventory Days Days638 757.8%  
Debtors Days Days115842 13.7%  
Net fixed assets Rs m26,57151,128 52.0%   
Share capital Rs m365531 68.8%   
"Free" reserves Rs m48,373127,140 38.0%   
Net worth Rs m48,738127,671 38.2%   
Long term debt Rs m00-   
Total assets Rs m56,574148,565 38.1%  
Interest coverage x60.41,209.5 5.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.5 91.5%   
Return on assets %12.912.3 105.0%  
Return on equity %14.714.3 102.8%  
Return on capital %18.018.6 96.8%  
Exports to sales %085.7 0.0%   
Imports to sales %10.219.8 51.7%   
Exports (fob) Rs mNA66,537 0.0%   
Imports (cif) Rs m2,77215,378 18.0%   
Fx inflow Rs m17,25666,537 25.9%   
Fx outflow Rs m2,77215,715 17.6%   
Net fx Rs m14,48450,822 28.5%   
CASH FLOW
From Operations Rs m8,49124,597 34.5%  
From Investments Rs m-4,771-27,076 17.6%  
From Financial Activity Rs m-3,630-7,972 45.5%  
Net Cashflow Rs m208-10,451 -2.0%  

Share Holding

Indian Promoters % 49.7 51.9 95.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 36.7 68.0%  
FIIs % 13.7 14.9 92.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 48.1 104.6%  
Shareholders   207,571 354,482 58.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Natco Pharma vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Divis Laboratories Share Price Performance

Period Natco Pharma Divis Laboratories S&P BSE HEALTHCARE
1-Day -2.11% 2.14% 1.18%
1-Month -3.19% -2.15% -0.75%
1-Year 72.80% 22.51% 61.82%
3-Year CAGR 4.96% -1.38% 18.16%
5-Year CAGR 10.96% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.